Vita Phoenix Extreme

MaxioCel MX4545 is a chitosan-based hemostatic wound dressing designed for rapid bleeding control in acute and chronic wounds. FDA 510(k) cleared, it is indicated for temporary external hemorrhage management and local wound care in vascular access and trauma applications. The dressing functions as an absorbable hemostat for both internal and external bleeding scenarios.

Chitosan-based hemostatic dressing designed for rapid bleeding control in acute wound management and surgical applications. The dressing leverages chitosan's natural coagulation properties to promote hemostasis and facilitate wound healing. Suitable for trauma care, surgical procedures, and emergency wound treatment settings.

MaxioCel MX1515 is a chitosan-based hemostatic wound dressing for controlling bleeding in vascular access sites and trauma wounds. FDA 510(k) cleared for temporary external hemorrhage management and acute/chronic wound treatment. The dressing provides rapid hemostasis for moderate to severe bleeding, lacerations, and abrasions in clinical and emergency settings.

An emergency trauma response product combining chitosan hemostatic materials with tactical rescue packs for battlefield and emergency rescue scenarios. It provides efficient blood control and comprehensive wound care for high-risk rescue situations.

Hemostatic wound dressing based on chitosan technology that achieves rapid bleeding control through electrostatic interaction between positively-charged chitosan and negatively-charged red blood cells and platelets. The product provides antimicrobial protection against multiple bacterial strains including antibiotic-resistant organisms, while simultaneously absorbing wound exudate and reducing inflammatory cytokine expression. Indicated for surgical hemostasis and acute wound management.

Chitosan hemostatic dressing is a bioabsorbable wound care product designed to control bleeding and promote hemostasis in surgical and trauma applications. The dressing utilizes chitosan, a natural biopolymer, to accelerate clot formation and maintain a moist wound environment. It is suitable for use in surgical procedures, emergency medicine, and acute wound management where rapid hemostasis is required.

MaxioCel Solution MS100 is a chitosan-based hemostatic wound dressing for control of moderate to severe bleeding in vascular access and trauma applications. FDA 510(k) cleared for temporary external hemorrhage management and acute wound treatment, with proven clinical use across Europe for over 5 years.

Chitosan-based hemostatic gauze dressing for rapid bleeding control in emergency and pre-hospital settings. Axiostat activates the body's natural clotting cascade to achieve hemostasis within minutes, reducing blood loss in trauma wounds. Non-adherent formulation minimizes tissue damage during removal.

MaxioCel MX1010 is a chitosan-based hemostatic wound dressing designed for bleeding control in vascular access and trauma applications. FDA 510(k) cleared, it provides rapid hemostasis for moderate to severe bleeding, external lacerations, and abrasions in both acute and chronic wound management settings.

Advanced wound dressing formulation utilizing chitosan for accelerated hemostasis. Indicated for acute wounds and surgical sites where rapid bleeding control is essential.

A rapid hemostatic dressing that achieves fast bleeding control within minutes of application, effective for moderate to heavy bleeding. The dressing is low-cost, easy to store and carry, suitable for different wound types, contains no shellfish or animal proteins, shows low risk of adverse reactions, and releases minimal heat to prevent skin burns.

Chitosan-based hemostatic dressing for controlling bleeding in wounds and surgical sites. Provides rapid hemostasis with natural biocompatible material.